相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Outcomes in patients with systemic sclerosis undergoing early vs delayed intervention with potential disease-modifying therapies
Keina Yomono et al.
RHEUMATOLOGY (2022)
Immunosuppressive Therapy After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients-High Efficacy of Rituximab
Michael Gernert et al.
FRONTIERS IN IMMUNOLOGY (2022)
Current advances in the treatment of systemic sclerosis
Heather Bukiri et al.
CURRENT OPINION IN PHARMACOLOGY (2022)
PROGRESSIVE INTERSTITIAL LUNG DISEASE IS FREQUENT ALSO IN LATE DISEASE STAGES IN SYSTEMIC SCLEROSIS PATIENTS FROM EUSTAR
A. M. Hoffmann-Vold et al.
ANNALS OF THE RHEUMATIC DISEASES (2022)
Impact of lung function decline on time to hospitalisation events in systemic sclerosis-associated interstitial lung disease (SSc-ILD): a joint model analysis
Michael Kreuter et al.
ARTHRITIS RESEARCH & THERAPY (2022)
Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party
Joerg Henes et al.
HAEMATOLOGICA (2021)
The effects of oral treatment for systemic sclerosis related pulmonary arterial hypertension: A systematic review and meta-analysis
Yunxia Lei et al.
MODERN RHEUMATOLOGY (2021)
Cardiac safe hematopoietic stem cell transplantation for systemic sclerosis with poor cardiac function: a pilot safety study that decreases neutropenic interval to 5 days
Richard K. Burt et al.
BONE MARROW TRANSPLANTATION (2021)
Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database
Anna-Maria Hoffmann-Vold et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
STRATUS: A Phase II Study of Abituzumab in Patients With Systemic Sclerosis-associated Interstitial Lung Disease
Dinesh Khanna et al.
JOURNAL OF RHEUMATOLOGY (2021)
Association of Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis With Marked Improvement in Health-Related Quality of Life
Nancy Maltez et al.
ARTHRITIS & RHEUMATOLOGY (2021)
Scleroderma epidemiology update
Leonardo Martin Calderon et al.
CURRENT OPINION IN RHEUMATOLOGY (2021)
Pulmonary hypertension in connective tissue diseases, new evidence and challenges
Madelon C. Vonk et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2021)
Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease
Aaron Waxman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Serum markers of pulmonary epithelial damage in systemic sclerosis-associated interstitial lung disease and disease progression
Carmel J. W. Stock et al.
RESPIROLOGY (2021)
Rituximab for the treatment of systemic sclerosis-interstitial lung disease
Michael Hughes et al.
RHEUMATOLOGY (2021)
Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis-associated Pulmonary Arterial Hypertension A Multicenter, Double-Blind, Randomized, Placebo-controlled Trial
Roham T. Zamanian et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)
Systemic Sclerosis and Associated Interstitial Lung Disease in Ontario, Canada: An Examination of Prevalence and Survival Over 10 Years
Janet E. Pope et al.
JOURNAL OF RHEUMATOLOGY (2021)
Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS)
Silvia Bellando-Randone et al.
Lancet Rheumatology (2021)
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial
Juergen Behr et al.
LANCET RESPIRATORY MEDICINE (2021)
BRENTUXIMAB VEDONTIN FOR SKIN INVOLVEMENT IN REFRACTORY DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS, INTERIM RESULTS OF A PHASE IIB OPEN-LABEL TRIAL
A. Fernandez-Codina et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Association Between Immunosuppressive Therapy and Incident Risk of Interstitial Lung Disease in Systemic Sclerosis
Sabrina Hoa et al.
CHEST (2021)
Tofacitinib in the treatment of skin and musculoskeletal involvement in patients with systemic sclerosis, evaluated by ultrasound
Rositsa Valerieva Karalilova et al.
RHEUMATOLOGY INTERNATIONAL (2021)
Rituximab as a Treatment Option after Autologous Hematopoietic Stem Cell Transplantation in a Patient with Systemic Sclerosis
Paul Gressenberger et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
Sine scleroderma, limited cutaneous, and diffused cutaneous systemic sclerosis survival and predictors of mortality
Sebastien De Almeida Chaves et al.
ARTHRITIS RESEARCH & THERAPY (2021)
Assessment of recent evidence for the management of patients with systemic sclerosis-associated interstitial lung disease: a systematic review
Anna-Maria Hoffmann-Vold et al.
ERJ OPEN RESEARCH (2021)
Rituximab in the treatment of systemic sclerosis-related interstitial lung disease: a systematic review and meta-analysis
Rudra P. Goswami et al.
RHEUMATOLOGY (2021)
Changes in skin score in early diffuse cutaneous systemic sclerosis are associated with changes in global disease severity
Boyang Zheng et al.
RHEUMATOLOGY (2020)
Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator-Initiated, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial
Dinesh Khanna et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Association between immunosuppressive therapy and course of mild interstitial lung disease in systemic sclerosis
Sabrina Hoa et al.
RHEUMATOLOGY (2020)
Skin improvement is a surrogate for favourable changes in other organ systems in early diffuse cutaneous systemic sclerosis
Tatiana Nevskaya et al.
RHEUMATOLOGY (2020)
Using Autoantibodies and Cutaneous Subset to Develop Outcome-Based Disease Classification in Systemic Sclerosis
Svetlana I. Nihtyanova et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Raynaud phenomenon and digital ulcers in systemic sclerosis
Michael Hughes et al.
NATURE REVIEWS RHEUMATOLOGY (2020)
Multidimensional tracking of phenotypes and organ involvement in a complete nationwide systemic sclerosis cohort
Havard Fretheim et al.
RHEUMATOLOGY (2020)
Effect of mycophenolate mofetil (MMF) on systemic sclerosis-related interstitial lung disease with mildly impaired lung function: a double-blind, placebo-controlled, randomized trial
G. S. R. S. N. K. Naidu et al.
RHEUMATOLOGY INTERNATIONAL (2020)
Predictive factors for treatment-related mortality and major adverse events after autologous haematopoietic stem cell transplantation for systemic sclerosis: results of a long-term follow-up multicentre study
Sandra van Bijnen et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial
Dinesh Khanna et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Systemic sclerosis-associated interstitial lung disease
Apostolos Perelas et al.
LANCET RESPIRATORY MEDICINE (2020)
Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo-Controlled Trial in Adults With Systemic Sclerosis
Robert Spiera et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Prominence of IL6, IGF, TLR, and Bioenergetics Pathway Perturbation in Lung Tissues of Scleroderma Patients With Pulmonary Fibrosis
Ludivine Renaud et al.
FRONTIERS IN IMMUNOLOGY (2020)
A randomised, double-blind, placebo-controlled, 24-week, phase II, proof-of-concept study of romilkimab (SAR156597) in early diffuse cutaneous systemic sclerosis
Yannick Allanore et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Factors associated with pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc)
Yuxuan Jiang et al.
AUTOIMMUNITY REVIEWS (2020)
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial
Dinesh Khanna et al.
LANCET RESPIRATORY MEDICINE (2020)
Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial
Lorinda Chung et al.
LANCET RHEUMATOLOGY (2020)
The need for a holistic approach for SSc-ILD - achievements and ambiguity in a devastating disease
Anna-Maria Hoffmann-Vold et al.
RESPIRATORY RESEARCH (2020)
Practical suggestions on intravenous iloprost in Raynaud's phenomenon and digital ulcer secondary to systemic sclerosis: Systematic literature review and expert consensus
Francesca Ingegnoli et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2019)
Management of systemic sclerosis-associated interstitial lung disease
David Roofeh et al.
CURRENT OPINION IN RHEUMATOLOGY (2019)
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease
Oliver Distler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Novel Imaging Approaches in Systemic Sclerosis-Associated Interstitial Lung Disease
Sydney B. Montesi et al.
CURRENT RHEUMATOLOGY REPORTS (2019)
Endothelin receptor antagonism during preeclampsia: a matter of timing?
Emilie Hitzerd et al.
CLINICAL SCIENCE (2019)
Biomarkers in systemic sclerosis-associated interstitial lung disease: review of the literature
Olivier Bonhomme et al.
RHEUMATOLOGY (2019)
Screening for pulmonary arterial hypertension in systemic sclerosis
Jason Weatherald et al.
EUROPEAN RESPIRATORY REVIEW (2019)
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
K. R. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts
Elizabeth R. Volkmann et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Autologous haematopoietic stem cell transplantation (AHSCT) in autoimmune disease adult patients in France: analysis of the long-term outcome from the French Society for Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)
Perrine Guillaume-Jugnot et al.
CLINICAL RHEUMATOLOGY (2019)
Haemodynamic definitions and updated clinical classification of pulmonary hypertension
Gerald Simonneau et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Risk stratification and medical therapy of pulmonary arterial hypertension
Nazzareno Galie et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Regional grafting of autologous adipose tissue is effective in inducing prompt healing of indolent digital ulcers in patients with systemic sclerosis: results of a monocentric randomized controlled study
Nicoletta Del Papa et al.
ARTHRITIS RESEARCH & THERAPY (2019)
Management of Raynaud's phenomenon in systemic sclerosis-a practical approach
Andreu Fernandez-Codina et al.
JOURNAL OF SCLERODERMA AND RELATED DISORDERS (2019)
Treatment of pulmonary arterial hypertension with the dual endothelin receptor antagonist macitentan: clinical evidence and experience
Catharina Belge et al.
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2019)
Belimumab for the Treatment of Early Diffuse Systemic Sclerosis Results of a Randomized, Double-Blind, Placebo-Controlled, Pilot Trial
Jessica K. Gordon et al.
ARTHRITIS & RHEUMATOLOGY (2018)
Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis
Christopher P. Denton et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study
Ariane L. Herrick et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Autologous Hematopoietic Stern Cell Transplantation for Systemic Sclerosis: A Systematic Review and Meta-Analysis
Roni Shouval et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
The challenge of establishing treatment efficacy for cutaneous vascular manifestations of systemic sclerosis
John D. Pauling
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2018)
Venous Thromboembolism in Systemic Sclerosis: Prevalence, Risk Factors, and Effect on Survival
Sindhu R. Johnson et al.
JOURNAL OF RHEUMATOLOGY (2018)
A systematic review and meta-analysis of the effects of topical nitrates in the treatment of primary and secondary Raynaud's phenomenon
Paul Curtiss et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma
K. M. Sullivan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Intravenous cyclophosphamide vs rituximab for the treatment of early diffuse scleroderma lung disease: open label, randomized, controlled trial
Geetabali Sircar et al.
RHEUMATOLOGY (2018)
Treatment Algorithms for Systemic Sclerosis According to Experts
Andreu Fernandez-Codina et al.
ARTHRITIS & RHEUMATOLOGY (2018)
Riociguat for the treatment of pulmonary arterial hypertension associated with connective tissue disease: results from PATENT-1 and PATENT-2
Marc Humbert et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial
John Gerry Coghlan et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Update of EULAR recommendations for the treatment of systemic sclerosis
Otylia Kowal-Bielecka et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature
Yvonne M. Ende-Verhaar et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Prognostic significance of computed tomography criteria for pulmonary veno-occlusive disease in systemic sclerosis-pulmonary arterial hypertension
Michelle J. Connolly et al.
RHEUMATOLOGY (2017)
Short-Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis
Nicole S. Goh et al.
ARTHRITIS & RHEUMATOLOGY (2017)
The Therapeutic Efficacy of Botulinum Toxin in Treating Scleroderma-Associated Raynaud's Phenomenon A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Ricardo J. Bello et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Mapping and predicting mortality from systemic sclerosis
Muriel Elhai et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Efficacy of Botulinum Toxin B Injection for Raynaud's Phenomenon and Digital Ulcers in Patients with Systemic Sclerosis
Sei-ichiro Motegi et al.
ACTA DERMATO-VENEREOLOGICA (2017)
Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis
Dinesh Khanna et al.
JOURNAL OF SCLERODERMA AND RELATED DISORDERS (2017)
Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme
Kathleen Morrisroe et al.
ARTHRITIS RESEARCH & THERAPY (2017)
Efficacy of sildenafil on ischaemic digital ulcer healing in systemic sclerosis: the placebo-controlled SEDUCE study
Eric Hachulla et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)
Nazzareno Galie et al.
EUROPEAN HEART JOURNAL (2016)
Clinical characteristics and predictors of gangrene in patients with systemic sclerosis and digital ulcers in the Digital Ulcer Outcome Registry: a prospective, observational cohort
Yannick Allanore et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
An Open-label, Phase II Study of the Safety and Tolerability of Pirfenidone in Patients with Scleroderma-associated Interstitial Lung Disease: the LOTUSS Trial
Dinesh Khanna et al.
JOURNAL OF RHEUMATOLOGY (2016)
Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial
Dinesh Khanna et al.
LANCET (2016)
BSR and BHPR guideline for the treatment of systemic sclerosis
Christopher P. Denton et al.
RHEUMATOLOGY (2016)
The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis
Dinesh Khanna et al.
ARTHRITIS CARE & RESEARCH (2016)
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial
Donald P. Tashkin et al.
LANCET RESPIRATORY MEDICINE (2016)
Lung Transplant in Patients with Scleroderma Compared with Pulmonary Fibrosis Short- and Long-Term Outcomes
Maria M. Crespo et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2016)
SURGICAL TREATMENT OF SYSTEMIC SCLEROSIS-IS IT JUSTIFIED TO OFFER PERIPHERAL SYMPATHECTOMY EARLIER IN THE DISEASE PROCESS?
Arash Momeni et al.
MICROSURGERY (2015)
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
N. Galie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Consensus best practice pathway of the UK Scleroderma Study Group: digital vasculopathy in systemic sclerosis
Michael Hughes et al.
RHEUMATOLOGY (2015)
Survival of Adults With Systemic Sclerosis Following Lung Transplantation A Nationwide Cohort Study
Elana J. Bernstein et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis A Randomized Clinical Trial
Jacob M. van Laar et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Fat Grafting to the Hand in Patients with Raynaud Phenomenon: A Novel Therapeutic Modality
Jonathan Bank et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2014)
Prediction of Pulmonary Complications and Long-Term Survival in Systemic Sclerosis
Svetlana I. Nihtyanova et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Phosphodiesterase-5 inhibitors for the treatment of secondary Raynaud's phenomenon: systematic review and meta-analysis of randomised trials
Matthieu Roustit et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Association of Gastroesophageal Factors and Worsening of Forced Vital Capacity in Systemic Sclerosis
Xuli Jerry Zhang et al.
JOURNAL OF RHEUMATOLOGY (2013)
Serum Interleukin 6 Is Predictive of Early Functional Decline and Mortality in Interstitial Lung Disease Associated with Systemic Sclerosis
Angelo De Lauretis et al.
JOURNAL OF RHEUMATOLOGY (2013)
The 15% Rule in Scleroderma: The Frequency of Severe Organ Complications in Systemic Sclerosis. A Systematic Review
Chayawee Muangchan et al.
JOURNAL OF RHEUMATOLOGY (2013)
Systemic sclerosis sine scleroderma: distinct features in a large Brazilian cohort
Roberta Goncalves Marangoni et al.
RHEUMATOLOGY (2013)
Meta-Analysis of Healing and Prevention of Digital Ulcers in Systemic Sclerosis
Theresa Tingey et al.
ARTHRITIS CARE & RESEARCH (2013)
Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database
Florian M. P. Meier et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
The REVEAL Registry Risk Score Calculator in Patients Newly Diagnosed With Pulmonary Arterial Hypertension
Raymond L. Benza et al.
CHEST (2012)
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
Marco Matucci-Cerinic et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Interstitial lung disease in systemic sclerosis
Guillaume Bussone et al.
AUTOIMMUNITY REVIEWS (2011)
Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial
Richard K. Burt et al.
LANCET (2011)
Associations With Digital Ulcers in a Large Cohort of Systemic Sclerosis: Results From the Canadian Scleroderma Research Group Registry
Sarit Khimdas et al.
ARTHRITIS CARE & RESEARCH (2011)
Efficacy of tadalafil in secondary Raynaud's phenomenon resistant to vasodilator therapy: a double-blind randomized cross-over trial
Padmanabha D. Shenoy et al.
RHEUMATOLOGY (2010)
Assessment of gastrointestinal symptoms in patients with systemic sclerosis in a UK tertiary referral centre
Nora M. Thoua et al.
RHEUMATOLOGY (2010)
Systemic Sclerosis: Bilateral Improvement of Raynaud's Phenomenon with Unilateral Digital Sympathectomy
Amy Wasserman et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2010)
The efficacy of complementary and alternative medicine in the treatment of Raynaud's phenomenon: a literature review and meta-analysis
Deanne Malenfant et al.
RHEUMATOLOGY (2009)
Interstitial lung disease in systemic sclerosis - A simple staging system
Nicole S. L. Goh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Autoantibodies and Microvascular Damage Are Independent Predictive Factors for the Progression of Raynaud's Phenomenon to Systemic Sclerosis A Twenty-Year Prospective Study of 586 Patients, With Validation of Proposed Criteria for Early Systemic Sclerosis
Martial Koenig et al.
ARTHRITIS AND RHEUMATISM (2008)
The registry of the German Network for Systemic Scleroderma:: frequency of disease subsets and patterns of organ involvement
N. Hunzelmann et al.
RHEUMATOLOGY (2008)
Changes in causes of death in systemic sclerosis, 1972-2002
Virginia D. Steen et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma
Rachel K. Hoyles et al.
ARTHRITIS AND RHEUMATISM (2006)
Anticoagulation in pulmonary arterial hypertension: a qualitative systematic review
S. R. Johnson et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
Thrombotic arteriopathy and anticoagulation in pulmonary hypertension
Sindhu R. Johnson et al.
CHEST (2006)
Cyclophosphamide versus placebo in scleroderma lung disease
Donald P. Tashkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Bosentan decreases the plasma concentration of sildenafil when coprescribed in pulmonary hypertension
GA Paul et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Comparison between iloprost and alprostadil in the treatment of Raynaud's phenomenon
B Marasini et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2004)
Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon
PA Merkel et al.
ARTHRITIS AND RHEUMATISM (2002)
Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine
B Coleiro et al.
RHEUMATOLOGY (2001)
分享论文
